SCHEMBL29626010

SCHEMBL29626010

CC1=C[C@H](c2ccccc2)OCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
SLC6A2 P23975 2/20 0.37
HTR2B P41595 2/20 0.37
SLC6A3 Q01959 2/20 0.37
ADRA1A P35348 1/20 0.37
CYP2C19 P33261 2/20 0.36
HTR1A P08908 1/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
KIF11 P52732 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.31
CHRM2 P08172 2/20 0.31
CHRM1 P11229 2/20 0.31
CHRM3 P20309 2/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
SLC6A4 P31645 1/20 0.31
HRH1 P35367 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4612040 1.00 TSHR (0.39) TSHRSLC6A2HTR2BSLC6A3ADRA1A
SCHEMBL12330057 0.82 TSHR (0.43) TSHRSLC6A2HTR2BSLC6A3ADRA1A
SCHEMBL21580201 0.73 CHRM5 (0.36) TSHRCYP2C19KMT2ACHRM2CHRM1
SCHEMBL21580195 0.72 KDM4E (0.34) TSHRHTR1AMEN1KMT2AKIF11
SCHEMBL21858945 0.69 GBA1 (0.33) TSHRSLC6A2HTR2BSLC6A3CYP2C19
SCHEMBL27165432 0.68 CYP2C19 (0.33) TSHRSLC6A2HTR2BSLC6A3ADRA1A
SCHEMBL1472469 0.68 CYP2C19 (0.33) TSHRSLC6A2HTR2BSLC6A3ADRA1A
SCHEMBL7355394 0.67 TSHR (0.44) TSHRSLC6A2HTR2BSLC6A3ADRA1A
SCHEMBL21858944 0.65 MEN1 (0.40) MEN1KMT2A
SCHEMBL5456537 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119486703-A Fragrance composition with lasting fragrance appearance 弗门尼舍有限公司 2025-02-18 CN claimed
CN-119403908-A Method for enhancing psychological performance and composition for use in the method 弗门尼舍有限公司 2025-02-07 CN claimed
EP-4232536-A1 A SYNERGISTIC PERFUMING COMPOSITION Firmenich SA (CH) 2023-08-30 EP claimed
EP-4229165-A1 A SYNERGISTIC PERFUMING COMPOSITION Firmenich SA (CH) 2023-08-23 EP claimed
CN-116568786-A Synergistic perfuming composition 弗门尼舍有限公司 2023-08-08 CN claimed
CN-116528818-A Synergistic perfuming composition 弗门尼舍有限公司 2023-08-01 CN claimed
WO-2022129371-A1 A SYNERGISTIC PERFUMING COMPOSITION FIRMENICH SA (CH) 2022-06-23 WO claimed
WO-2022129351-A1 A SYNERGISTIC PERFUMING COMPOSITION FIRMENICH SA (CH) 2022-06-23 WO claimed
CN-122028974-A Ribonucleic acid-based microcapsules 弗门尼舍有限公司 2026-05-12 CN disclosed
US-12616948-B2 Polyamide microcapsules FIRMENICH SA (CH) 2026-05-05 US disclosed
EP-4711037-A2 PERFUME FORMULATION FOR DELIVERY SYSTEM Firmenich SA (CH) 2026-03-18 EP disclosed
EP-4711438-A2 PERFUME DELIVERY SYSTEM Firmenich SA (CH) 2026-03-18 EP disclosed
EP-4706627-A2 LAUNDRY COMPOSITION Firmenich SA (CH) 2026-03-11 EP disclosed
EP-4077624-B1 PERFUME FORMULATION FOR DELIVERY SYSTEM FIRMENICH & CIE (CH) 2026-02-11 EP disclosed
WO-2022136008-A1 PROCESS FOR PREPARING POLYESTER MICROCAPSULES FIRMENICH SA (CH) 2022-06-30 WO disclosed
WO-2022136007-A1 PROCESS FOR PREPARING POLYESTER MICROCAPSULES FIRMENICH SA (CH) 2022-06-30 WO disclosed
WO-2022129371-A1 A SYNERGISTIC PERFUMING COMPOSITION FIRMENICH SA (CH) 2022-06-23 WO disclosed
WO-2022129351-A1 A SYNERGISTIC PERFUMING COMPOSITION FIRMENICH SA (CH) 2022-06-23 WO disclosed
EP-3774017-B1 PROCESS FOR PREPARING POLYSUCCINIMIDE DERIVATIVES-BASED MICROCAPSULES FIRMENICH & CIE (CH) 2022-06-15 EP disclosed
US-20220175635-A1 COMPOSITE MICROCAPSULES FIRMENICH SA (CH) 2022-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220175635-A1 COMPOSITE MICROCAPSULES PLIN5, LIPA, PHOSPHO1 TSHR 4875/4885SLC6A2 4069/4885HTR2B 864/4885
US-12616948-B2 Polyamide microcapsules HDHD5, DDC, USP39 TSHR 2043/4885SLC6A2 4372/4885HTR2B 2037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.